Sutro Biopharma (STRO) earnings · rev $102.5M
These earnings events as JSON? API free 100/daySutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
This STRO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported STRO revenue for 2025-12-31 was $102.5M. Net income was -$191.1M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. STRO currently screens at market cap $470.8M.
When the next STRO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 65.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full STRO research stays on the stock page; the tape stays on the quote page.
STRO earnings FAQ
What are STRO's latest revenue and net income?
Latest cached Sutro Biopharma (STRO) revenue for Dec 31, 2025 was $102.5M. Net income was -$191.1M. Statements: https://lician.com/financials/stro
What is STRO's latest diluted EPS?
Latest cached Sutro Biopharma (STRO) diluted EPS for Dec 31, 2025 was -$22.49.
What period does the latest STRO earnings print cover?
The latest cached Sutro Biopharma (STRO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did STRO revenue change from the prior cached period?
Cached Sutro Biopharma (STRO) revenue was up 65.2% from $62.0M (Dec 31, 2024) to $102.5M (Dec 31, 2025). Statements: https://lician.com/financials/stro
Where are STRO earnings listed?
Cached earnings facts for Sutro Biopharma (STRO) are listed at https://lician.com/earnings/stro. Statements: https://lician.com/financials/stro
Not investment advice.